In August 2017, MAPS raised nearly $100,000 in new donations and pledges from 572 supporters. During August, MAPS raised funds for the Zendo Project, a psychedelic harm reduction and peer counseling program.
MAPS is moving forward with our research on MDMA-assisted psychotherapy for the treatment of PTSD. Phase 3 studies will cost between $25-$35 million for both FDA and European Medicines Agency (EMA) approval. With $12.5 million in hand or in multi-year pledges, there’s still a funding gap we need to close.
We extend a special thanks to those who so generously supported MAPS last month:
- Fred and Kate Weber ($10,000)
- AmazonSmile Foundation ($1,800)
- Chris Coburn ($1,000)
- Howard Fallon ($1,000)
MDMA/PTSD Phase 3 Studies
- Ullmann Family Foundation ($20,000)
- Riverstyx Foundation ($30,000)
- Anonymous ($17,508)
- Kirk Strawn ($1,000)
- Anonymous ($1,000)
MAPS relies on the generosity of individual donors to achieve our mission. Psychedelic science is again being conducted under federal guidelines, but no funding for psychedelic psychotherapy research is yet available from governments or major foundations.
Help us reach our goal to make MDMA a medicine by 2021 by establishing a monthly gift of $10 or more. maps.org/donate